Stock_Titan
Posted - 1 day ago
$TCRX TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-upcoming-presentations-at-the-2024-n8islnymryjx.html
Stocks4thought
Posted - 1 day ago
$TCRX Look In good
CheckingMorons
Posted - 1 day ago
$TCRX wow 98 % institutional jeez Christ this is very solid
Stock_Titan
Posted - 1 day ago
$TCRX TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-exercise-of-underwriters-option-to-xeyjlltqu3am.html
Thestocktraderhubzee
Posted - 1 day ago
WATCHLIST APR 24 2024
$TCRX Wedbush Reiterates Outperform on TScan Therapeutics, Maintains $10 Price Target
$SWN Stifel Maintains Hold on Southwestern Energy, Raises Price Target to $7.6
$VTLE Stifel Maintains Buy on Vital Energy, Raises Price Target to $75
$EOG Stifel Maintains Buy on EOG Resources, Lowers Price Target to $150
$CACI Stifel Maintains Buy on CACI International, Raises Price Target to $430
soll
Posted - 2 days ago
$TCRX Ownership and Control: Lynx1 Capital Management LP is a Delaware limited partnership that was formed in May 2020. The firm is owned and controlled by Weston Nichols, who serves as the Chief Investment Officer. Additionally, Lynx1 Capital Advisors LLC acts as the sub-adviser to the funds managed by Lynx1 Capital Management LP1. Recent Transaction: In a recent transaction, Lynx1 Capital Management LP, a significant shareholder in TScan Therapeutics, Inc. (NASDAQ: TCRX), acquired pre-funded warrants to purchase 5 million shares of the company’s common stock. These warrants were bought on April 19, 2024, at a price range of $7.1299 per share, resulting in a total investment of approximately $35.66 million. The pre-funded warrants allow the holder to purchase the company’s common stock at a predetermined price and come with certain terms and conditions2.
Stock_Titan
Posted - 3 days ago
$TCRX TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-upcoming-presentations-at-the-american-2sdqzsre679a.html
Stocks4thought
Posted - 3 days ago
$MRKR Major force soon ot $TCRX
NorthWestHawk
Posted - 6 days ago
Watching $TCRX. Will it bounce from its 50-day SMA at $7 in volume?
Stock_Titan
Posted - 6 days ago
$TCRX TScan Therapeutics Announces Closing of Upsized Public Offering
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-closing-of-upsized-public-3nis6cwh1xxx.html
DonCorleone77
Posted - 1 week ago
$TCRX TScan Therapeutics 2.473M share Spot Secondary priced at $7.13 The deal size was raised to $150M in common stock from $125M in common stock. Morgan Stanley and TD Cowen acted as joint book running managers for the offering.
Jackofalltrade5
Posted - 1 week ago
$TCRX 3 tomorrow!?
DonCorleone77
Posted - 1 week ago
$TCRX TScan Therapeutics announces $125M common stock offering TScan Therapeutics announced that it has commenced an underwritten public offering of $125M of shares of its voting common stock and, in lieu of voting common stock, to certain investors that so choose, pre-funded warrants to purchase shares of voting common stock. All shares of voting common stock and pre-funded warrants to be sold in the offering will be offered by TScan. The company intends to use the net proceeds from the offering for general corporate purposes. Morgan Stanley and TD Cowen are acting as joint book-running managers for the offering. LifeSci Capital is acting as Lead Manager, and BTIG, H.C. Wainwright & Co. and Needham & Company are each acting as co-managers for the offering.
Stock_Titan
Posted - 1 week ago
$TCRX TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-launch-of-125-million-proposed-public-9ruxzspm4hrh.html
Stock_Titan
Posted - 1 week ago
$TCRX TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-provides-clinical-pipeline-update-and-highlights-o1d4ckrg5zo7.html
InsightInvestsub
Posted - 1 week ago
🚀 Watching $TCRX closely! Analysts target $11, bullish EMAs signal strong momentum. Earnings drop May 7, could be a game-changer. Stay tuned for updates and join the discussion! 💡📈 #DayTrading #BiotechStocks https://open.substack.com/pub/insightinvestsub/p/tcrx-investment-newsletter-embrace?r=2brmn5&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
Stocks4thought
Posted - 1 week ago
$RANI LSD trips $TCRX $INDP
Stocks4thought
Posted - 2 weeks ago
$TCRX new high coming
Stocks4thought
Posted - 2 weeks ago
$TCRX Looking for $8 HCT Chimerism. OVER L(OOKED.
Stocks4thought
Posted - 2 weeks ago
$TCRX Dirt cheap
Stocks4thought
Posted - 2 weeks ago
$TCRX Life of Riley$
Stock_Titan
Posted - 3 weeks ago
$TCRX TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-upcoming-presentation-at-the-23rd-qw6jpd5qyt2f.html
MRKR2025
Posted - 03/27/24
@type12 $IOVA $VINC $MAIA $BLUE $TCRX
Stocks4thought
Posted - 03/27/24
$TCRX $9 well that's on life in the day of a cat......................$8 more live to surpass $9
kiwitc2000
Posted - 03/27/24
$TCRX Testing the nines. If it can hold it there's no resistance until the 12s. That would put it back at the IPO level.
Stocks4thought
Posted - 03/27/24
$TCRX $10 next stop.................$9.11 is the stepwise move. Hit that PPS...........ot $Vor platform is under appreciated.
Stocks4thought
Posted - 03/27/24
$TCRX Always been my absolute favorite---------- post $AMGN and the secondary----------$21 target...........Chimerism!
FlynancialAnalyst
Posted - 03/27/24
$TCRX institutions getting $INZY and loading this ~$380M mc $XBI name.